CUAMC
China Universal Asset Management Company’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-22,158
| Closed | -$23K | – | 503 |
|
|
2024
Q3 | $23K | Buy |
22,158
+8,679
| +64% | +$9.03K | ﹤0.01% | 403 |
|
|
2024
Q2 | $23.3K | Sell |
13,479
-7,947
| -37% | -$13.7K | ﹤0.01% | 389 |
|
|
2024
Q1 | $51.2K | Buy |
21,426
+8,546
| +66% | +$20.4K | 0.01% | 411 |
|
|
2023
Q4 | $42.9K | Buy |
12,880
+10,454
| +431% | +$34.8K | 0.01% | 384 |
|
|
2023
Q3 | $9.07K | Buy |
2,426
+1,193
| +97% | +$4.46K | ﹤0.01% | 354 |
|
|
2023
Q2 | $5.27K | Buy |
1,233
+179
| +17% | +$764 | ﹤0.01% | 364 |
|
|
2023
Q1 | $7.21K | Buy |
1,054
+264
| +33% | +$1.81K | ﹤0.01% | 334 |
|
|
2022
Q4 | $6.26K | Buy |
790
+62
| +9% | +$491 | ﹤0.01% | 270 |
|
|
2022
Q3 | $7K | Buy |
+728
| New | +$7K | ﹤0.01% | 232 |
|